Ever Supreme Bio Technology Co., Ltd reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 438.84 million compared to TWD 70.6 million a year ago. Net income was TWD 369.6 million compared to net loss of TWD 106.83 million a year ago.

Basic earnings per share from continuing operations was TWD 5.4545 compared to basic loss per share from continuing operations of TWD 1.7364 a year ago. Diluted earnings per share from continuing operations was TWD 5.4 compared to diluted loss per share from continuing operations of TWD 1.7364 a year ago.